Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/9/2020
SIETES contiene 93097 citas

 
 
<< anterior 21 a 40 de 799 siguiente >>
Presentar resultados
Seleccionar todas
21.Enlace a cita original
Payne RA, Avery AJ, Duerden M, Saunders CL, Simpson CR, Abel GA. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol 2014;70:575581. [Ref.ID 97551]
22. Cita con resumen
Anónimo. FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients . U.S. Food and Drug Administration 2014:8 de mayo. [Ref.ID 97512]
23. Cita con resumen
Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Epi M, Alonso-Coello P, Kurz A, Villar JC, Sigamani A, Biccard BM, Meyhoff ChS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, Botto F, Lurati Buse G, Xavier D, Chan MTV, Tiboni M, Cook D, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, VanHelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin L, Le Manach Y, Pogue J, Gao P, Whitlock R, Lamy A, Kearon C, Baigent C, Chow C, Pettit S, Chrolavicius S, Yusuf S, for the POISE-2 investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014;370:1494-503. [Ref.ID 97484]
24.Enlace a cita originalTiene citas relacionadas
Rezkalla S, Kloner RA. Recreational marijuana use: is it safe for your patient?. Journal of the American Heart Association 2014;3:e000904. [Ref.ID 97482]
25.Enlace a cita originalTiene citas relacionadas
Jouanjus E, Lapeyre-Mestre M, Micallef J, The French association of the regional abuse and dependence monitoring centres (CEIP-A) working group on cannabis complications. Cannabis use: signal of increasing risk of serious cardiovascular disorders. Journal of the American Heart Association 2014;3:e000638. [Ref.ID 97472]
26.Tiene citas relacionadas Cita con resumen
Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-deJong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB, Franco OH. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014;348:g1903. [Ref.ID 97467]
27.Tiene citas relacionadas
Welsh P, Sattar N. Vitamin D and chronic disease prevention. BMJ 2014;348:g2280. [Ref.ID 97464]
28. Cita con resumen
Kmietowicz Z. Analysis fuels debate on statins for low risk people. BMJ 2014;348:g2370. [Ref.ID 97457]
29. Cita con resumen
Albert L, González-Clemente JM. Prevención cardiovascular primaria con estatinas en la diabetes mellitus tipo 2: ¿es hora de cambiar de estrategia?. Med Clin (Barc) 2014;142:358-9. [Ref.ID 97378]
30. Cita con resumen
Ruff ChT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014;383:955-62. [Ref.ID 97286]
31. Cita con resumen
Vaqué J, Pumarola T. Gripe 2014. Med Clin (Barc) 2014;142:255-8. [Ref.ID 97269]
32.Tiene citas relacionadas Cita con resumen
Threapleton DE, Greenwood DC, Evans ChEL, Cleghorn ChL, Nykjaer C, Woodhead Ch, Cade JE, Gale ChP, Burley VJ. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 2013;347:f6879. [Ref.ID 97234]
34.Tiene citas relacionadas Cita con resumen
Anónimo. Macitentan (Opsumit) for pulmonary arterial hypertension. Med Lett Drugs Ther 2014;56:15-6. [Ref.ID 97223]
35. Cita con resumen
White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Malaria. Lancet 2014;383:723-35. [Ref.ID 97151]
36.
Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014;383:69-82. [Ref.ID 97052]
37.Tiene citas relacionadas Cita con resumen
Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, White HD, Harrington RA, for the CHAMPION Investigators. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet 2013;382:1981-92. [Ref.ID 96671]
38.Tiene citas relacionadas
Mehta SR. Cangrelor: a new CHAMPION for percutaneous coronary intervention. Lancet 2013;382:1960-2. [Ref.ID 96669]
40. Cita con resumen
Blanco Rubio N, Llorens Eizaguerri M, Seral García B, Burillo Fuertes P, Ranera García M, Albareda Albareda J. Hierro intravenoso preoperatori como estrategia de ahorro de sangre en cirugía de fractura de cadera. Med Clin (Barc) 2013;141:371-5. [Ref.ID 96506]
Seleccionar todas
 
<< anterior 21 a 40 de 799 siguiente >>